WHO Experts Recommend Countries Administer Lower Dose Polio Vaccines Intradermally To Make Dwindling Stocks Last Longer

CIDRAP News: WHO panel recommends dose-sparing strategy for IPV polio vaccine
“To help alleviate worse-than-expected shortages in inactivated polio vaccine (IPV), outside experts who advise the World Health Organization (WHO) on vaccine issues [last] week recommended that countries prepare to administer IPV intradermally as a dose-sparing tactic…” (Schnirring, 10/21).

Reuters: Polio vaccine makers failing to make enough doses: WHO experts
“…WHO’s Strategic Advisory Group of Experts (SAGE), which meets twice a year, said a severe shortage of inactivated vaccine means many countries should use a fractional dose, via an intradermal rather than intramuscular injection, allowing each dose to go twice as far…” (Miles, 10/21).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.